New laser and cream combo aims to fade age spots

NCT ID NCT07239726

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a laser device called Epilady, used with or without a special cream, to lighten dark age spots on the hands and forearms of healthy women aged 35 to 70. Over 84 days, doctors will check how much the spots fade and how well the treatment is tolerated. The goal is to see if this combination is a safe and effective way to reduce the appearance of lentigo spots.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
laser device and depigmenting topical cream
What this could lead to
If it works, this could offer a new option for reducing the appearance of age spots without invasive procedures.
What could go wrong
This is a small, early-stage trial with only 44 participants. The results may not apply to everyone, and the treatment might not work as well as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLAR LENTIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CIDP Ltée

    Phoenix, Mauritius

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.